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Study Objectives: Sarcopenia, or loss of muscle mass, occurs with aging and results in frailty, disability, cardiovascular disease, and insulin resistance. Recently, 
researchers have asserted that sarcopenia is not an inevitable process, but is a modifiable condition. Adequate sleep duration is also important to maintain good 
physical and mental health. Therefore, the aim of our study was to examine the association between sleep duration and sarcopenia in Korean adults.
Methods: Data from 16,148 participants (7,158 men and 8,990 women) were analyzed from the 2008–2011 Korean National Health and Nutrition Examination 
Survey (KNHANES). We defined sarcopenia as one standard deviation below the sex-specific means of the appendicular skeletal muscle/height-squared 
values of a young reference group. Participants were categorized into 5 groups according to sleep duration. The odds ratios (OR) and 95% confidence 
intervals (95% CI) for sarcopenia according to sleep duration were calculated using multiple logistic regression analysis.
Results: The prevalence of sarcopenia was 14.3% in the total population (males 18.7%, females 9.7%). Compared to the 7 hours of sleep group, the OR 
(95% CI) for sarcopenia of the long sleep duration group (9 hours or more) was 1.589 (1.100–2.295) after controlling for confounding factors. From the 
results of subgroup analysis, high-risk groups for sarcopenia are as follows: 40–64 years old (OR = 1.868), normal body mass index (OR = 1.516), smoking 
(OR = 2.219), no regular exercise (OR = 1.506) in long sleepers.
Conclusions: Long sleep duration (9 hours or longer) is independently associated with sarcopenia in Korean adults.
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INTRODUCTION
Sarcopenia is a condition characterized by the loss of skeletal 
muscle mass, strength, and function.1 During normal aging in 
humans, muscle mass decreases by approximately 3% to 5% 
every 10 years after the age of 30 years.2 Especially in older 
people, sarcopenia is closely related to frailty, disability, and 
falls. Furthermore, emerging evidence suggests that sarco-
penia is associated with many cardiometabolic diseases such 
as insulin resistance, diabetes mellitus, and cardiovascular 
disease.3–6 Although decline in muscle mass is an inevitable 
process with aging, recent studies suggest that sarcopenia is 
a modifiable condition, and the rate of decline of muscle mass 
can be slowed by adopting a healthy lifestyle. The pathophysi-
ology of sarcopenia is multifactorial. Physical inactivity, low 
body weight, malnutrition, and a reduction in endocrine func-
tion have been identified as risk factors in several studies.7,8
An adequate amount of sleep plays an important role in 
physical health and quality of life. Therefore, researchers have 
tried to suggest an appropriate sleep duration. Although sleep 
duration varies across life span, the National Sleep Foundation 
has recommended that sleep duration be 7 to 8 hours.9 Many 
previous studies have established that both too little sleep and 
too much sleep are related to all-cause mortality,10 cardiovas-
cular disease,11–13 diabetes,14 and metabolic syndrome.14,15
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Considering the aforementioned findings, sarcopenia may 
be a detrimental preclinical condition that affects the relation-
ship between sleep duration and adverse health outcomes. The 
association between sleep duration and sarcopenia has not 
been fully examined. Thus, in this study, we aimed to investi-
gate the association between sleep duration and sarcopenia in 
Korea using a nationally representative dataset.
METHODS
Study Population
The Korea National Health and Nutrition Examination Survey 
(KNHANES) is a national population-based survey assessing 
BRIEF SUMMARY
Current Knowledge/Study Rationale: Although adequate 
sleep duration is an important factor of health management, few 
researchers have investigated the association between sleep 
duration and sarcopenia. We studied the association between sleep 
duration and sarcopenia.
Study Impact: We found that long sleep duration was associated 
with sarcopenia. In particular, this association was more apparent in 
middle-aged subjects.
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the health and nutrition status of Korean people. This survey 
has been conducted by the Korea Centers for Disease Control 
and Prevention (KCDC) since 1998 and is composed of a health 
interview, health examination, and nutrition survey.
Response rates in 2008, 2009, 2010, and 2011 KNHANES 
were 77.8%, 82.2%, 81.9%, and 80.0%, respectively; a to-
tal of 37,753 citizens (9,744 in 2008; 10,533 in 2009; 8,958 in 
2010; 8,518 in 2011) participated in at least 1 of the 3 survey 
components. Survey items in KNHANES have partially been 
changed. Body composition and bone density were measured 
only during the period of July 2008 to May 2011 and checked 
in individuals who were 10 years and older.
Trained medical staff performed the health examination and 
interview at a mobile center for each primary sampling unit. 
The sampling design of this study was multistage clustered 
probability and the sample weights for participants were al-
located to best represent all of Koreans after considering the 
nonresponse rate and poststratification.16
We excluded people who were not checked by dual-energy 
x-ray absorptiometry (younger than 10 years, n = 5,206), over 
the periods of January 2008 to June 2008 and June 2011 to 
December 2011 (n = 9,857). We also excluded patients who 
were younger than 20 years (n = 2,983) and 3,739 subjects who 
had missing data in at least one of the following components: 
health questionnaires, blood samples, and/or anthropometric 
variables. In the end, data from 16,148 participants (7,158 men 
and 8,990 women) were analyzed in this study. Figure 1 il-
lustrated the data selection process. The KNHANES was ap-
proved by the Institutional Review Board of the KCDC (IRB 
No: 2008-04EXP-01-C, 2009-01CON-03-2C, 2010-02CON-
21-C, 2011-02CON-06C), and written consent was obtained 
from all of the participants before this survey.
Definition of Sarcopenia
In the KNHANES, appendicular skeletal mass (ASM) was 
measured using dual-energy x-ray absorptiometry (QDR 
4500A; Hologic Inc., Bedford, Massachusetts, United States). 
This is one of the recommended tools for quantifying sarco-
penia.17 ASM was calculated as the sum of the lean soft tis-
sue mass (non-fat and non-bone mass) in the arms and legs, 
which was used to approximate skeletal muscle mass. To define 
the cutoff value for sarcopenia, we used the sex-specific mean 
and standard deviation of the ASM/height2 according to rec-
ommendations of the Asian Working Group for Sarcopenia.1,18 
Also, we defined sarcopenia as 1 standard deviation below the 
sex-specific means of the ASM/height2 values of a young ref-
erence group (healthy men and women aged 20–39 years).1,19 
The cutoff values for sarcopenia were 6.98 kg/m2 for males and 
4.95 kg/m2 for females.
Sleep Duration
In this survey, sleep duration was assessed by self-report us-
ing the following question: “How long do you usually sleep a 
day?” Subjects were categorized into 5 groups: ≤ 5, 6, 7, 8, and 
more than 9 hours.
Covariates
Body weight and height were measured to the nearest 0.1 kg 
and 0.1 cm, respectively. Participants wore light indoor clothes 
without shoes during measurement. Body mass index (BMI) 
was calculated by dividing weight (kg) by the square of height 
(m2). BMI was categorized into 3 groups according to the World 
Health Organization and Korean Society for the Study of Obe-
sity standards20,21: thin < 18.5 kg/m2, normal 18.5–24.9 kg/m2, 
and overweight/obese ≥ 25 kg/m2. Systolic blood pressure and 
diastolic blood pressure were measured 3 times in the right 
arm. Hypertension was defined as follows: systolic blood pres-
sure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg or 
taking hypertension medication. Blood samples were collected 
in the morning after an overnight fast and analyzed using a 
Hitachi Automatic Analyzer 7600 (Hitachi, Tokyo, Japan). The 
subjects with diabetes were defined as follows: fasting blood 
glucose level ≥ 126 mg/dL or taking diabetes medication or 
insulin. Participants were also asked about their lifestyle be-
haviors, including cigarette smoking and alcohol consumption. 
Smoking status was categorized into “current smoking” and 
“no current smoking.” For alcohol consumption, we defined 
“alcohol intake” as drinking at least 7 servings for men and 5 
servings for women 2 or more times a week. The International 
Figure 1—Data management of the study population from 
2008–2011 KNHANES.
DEXA = dual-energy x-ray absorptiometry, KNHANES = Korean 
National Health Examination and Nutrition Survey.
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Physical Activity Questionnaire was adopted to determine 
the level of physical activity. “Regular exercise” was defined 
as ≥ 20 minutes of vigorous-intensity physical activity for ≥ 3 
days a week, or ≥ 30 minutes of light- or moderate-intensity 
physical activity ≥ 5 days a week. Socioeconomic status was 
assessed with a face-to-face interview. Household income 
was grouped into quartiles and ranked from lowest to highest. 
Education level was categorized as follows: less than elemen-
tary school, middle school, high school, and college or more. 
Employment status was divided into 2 groups: employed and 
unemployed.
Work schedules were classified as daytime work (from 6:00 
am to 6:00 pm), evening work (from 2:00 pm to midnight), 
night work (from 9:00 pm to 8:00 am), and shift work (includ-
ing day-and-night rotating shift, 24-hour rotating shift, and 
split shift).
Statistical Analysis
Statistical analyses were applied to the sampling weights in or-
der to represent the entire Korean population. Characteristics 
of the study population were analyzed using either a weighted 
chi-square test for categorical variables and weighted one-way 
analysis of variance for continuous variables. The odds ratios 
(OR) and 95% confidence intervals (CI) for sarcopenia were 
determined using multiple logistic regression analysis after ad-
justing confounding variables. To confirm our results, we ana-
lyzed multiple logistic regression models in both the general 
population and the apparently healthy population, after exclud-
ing patients with a diagnosis of cancer, chronic kidney disease, 
liver disease, thyroid disease, rheumatism, stroke, angina, or 
myocardial infarction (n = 1,209). We also analyzed multino-
mial logistic models to investigate the relationship between 
sarcopenia and sleep duration.
We further conducted subgroup analyses by sex, age, BMI, 
exercise, smoking, alcohol, and employment groups, and used 
Bonferroni correction for multiple testing. We also described 
the data that compare the demographic and physical informa-
tion between analyzed subjects and those who were not (see 
Appendix 1 in the supplemental material). There was a low 
possibility of having selection bias in the participation rate, 
because we applied sampling weights to account for complex 
sampling.
All analyses were conducted using SPSS statistical soft-
ware, version 23.0 (IBM Corp., Armonk, New York, United 
States). A value of P < .05 was considered statistically signifi-
cant, and all statistical tests were two-sided.
RESULTS
Table 1 shows characteristics of the study population. Of the 
16,148 participants included in this study, there were 7,158 men 
(44.3%) and 8,990 women (55.7%). The results are presented 
as mean ± standard error (SE) for continuous variables and 
numbers (percentage) for categorical variables. There were 
13,843 participants (85.7%) without sarcopenia and 2,305 par-
ticipants (14.3%) with sarcopenia. Of the men, 1,339 (18.7%) 
had sarcopenia. Of the women, 872 (9.7%) had sarcopenia. The 
mean ± SE of the age of the participants without sarcopenia 
and with sarcopenia was 44.1 ± 0.2 and 45.2 ± 0.5 years, re-
spectively. The prevalence of sarcopenia according to sleep 
duration was as follows: 13.0% in those who slept ≤ 5 hours, 
12.8% for 6 hours, 13.1% for 7 hours, 15.9% for 8 hours, and 
20.8% for ≥ 9 hours. In this study population, the mean ± SE 
value of sleep duration was 6.9 ± 0.0. The associations between 
sleep duration and sarcopenia are presented in Table 2 and 
Appendix 2 in the supplemental material. Compared with the 
group who slept 7 hours, the corresponding OR of the group 
who slept more than 9 hours for sarcopenia was 1.589 (95% 
CI 1.100–2.295), after adjusting for age, sex, BMI, household 
income, regular exercise, current smoking, alcohol consump-
tion, hypertension, work schedule, and employment status. In 
an apparently healthy population, these significant associations 
remained after adjusting the same confounding factors. In 
multinomial logistic regression analysis, the OR of sarcopenia 
group for long sleep duration (≥ 9 hours) was 1.621 (1.108–
2.371) (see Appendix 2 in the supplemental material).
Table 3 shows the results of all adjusted logistic regres-
sion analyses between sleep duration and sarcopenia in sub-
groups. In subgroup analysis, when using the 7-hour sleep 
duration group as a reference, we found significantly positive 
associations between sleep duration and sarcopenia in partici-
pants with the following characteristics: middle-aged, with a 
18.5 ≤ BMI < 25 kg/m2, current smokers, and did not exercise 
regularly.
DISCUSSION
In the current study, we demonstrated that, compared to par-
ticipants who sleep an average of 7 hours per day, those who 
sleep ≥ 9 hours per day were significantly more likely to have 
sarcopenia in the Korean population. This association was still 
significant after adjusting for health status (BMI, smoking, 
exercise, alcohol consumption, and hypertension) and socio-
economic status (age, sex, household income, employment, 
and work schedule). After adjusting for the same confound-
ing factors, significant associations between sleep duration and 
sarcopenia were found in participants with the following char-
acteristics: middle-aged, with 18.5 ≤ BMI < 25 kg/m2, current 
smokers, and did not exercise regularly. In addition, despite the 
lack of significant significance, U-shaped associations between 
sleep duration and sarcopenia were shown in most subgroups. 
Risk factors of sarcopenia have not yet been fully investigated, 
and some risk factors shown in our study are consistent with 
those from previous studies. Castillo et al. identified both cur-
rent smoking and physical inactivity as modifiable risk fac-
tors for sarcopenia.22 Although the sex-specific prevalence 
of sarcopenia varies by country, many observational studies, 
especially for the Korean population, found a higher preva-
lence of sarcopenia in men.1,23,24 Some inconsistent findings 
existed regarding the relationship between alcohol and sarco-
penia. For instance, a number of previous studies suggested 
that alcohol decreased muscle protein synthesis.25 However, a 
meta-analysis established that there was no significant associa-
tion between alcohol consumption and sarcopenia (OR [95% 
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CI] for sarcopenia in the drinking group = 0.77 [0.67–0.88]).26 
Our study also showed that nonalcohol drinkers had a higher 
OR (OR [95% CI] = 1.417 [1.107–1.813]). Further research 
is needed to confirm the effects of alcohol consumption on 
sarcopenia. Aging and low BMI were significant risk fac-
tors for sarcopenia.27 However, in our study, the middle-aged 
Table 1—Characteristics of study population.
Total Without Sarcopenia With Sarcopenia P a
Total, n (%) 16,148 13,843 (85.7) 2,305 (14.3)
Sleep duration (hours), n (%)  < .001
≤ 5 2,307 1,990 (87.0) 317 (13.0)
6 4,150 3,612 (87.2) 538 (12.8)
7 4,753 4,122 (86.9) 631 (13.1)
8 3,646 3,080 (84.1) 566 (15.9)
≥ 9 1,292 1,039 (79.2) 253 (20.8)
Sex, n (%)  < .001
Male 7,158 5,819 (81.3) 1,339 (18.7)
Female 8,990 8,118 (90.3) 872 (9.7)
Age (years), mean ± SE 44.1 ± 0.2 44.0 ± 0.2 45.2 ± 0.5 .004
Body mass index (kg/m2), n (%)  < .001
Thin 807 306 (37.9) 501 (62.1)
Normal 10,270 8,524 (83.0) 1,746 (17.0)
Overweight 5,071 5,005 (98.7) 66 (1.3)
Household income level, n (%)  < .001
Q1 (Lowest) 2,471 2,029 (82.1) 442 (17.9)
Q2 4,263 3,645 (85.5) 618 (14.5)
Q3 4,796 4,148 (86.5) 648 (13.5)
Q4 (Highest) 4,618 4,013 (86.9) 605 (13.1)
Educational level, n (%) .188
Less than elementary school 2,907 2,491 (85.7) 416 (14.3)
Middle school 1,582 1,354 (85.6) 228 (14.4)
High school 6,330 5,475 (86.5) 855 (13.5)
College 5,329 4,518 (84.8) 811 (15.2)
Regular exercise, n (%) .001
Yes 8,655 7,521 (86.9) 1,134 (13.1)
No 7,493 6,324 (84.4) 1,169 (15.6)
Current smoking, n (%)  < .001
Yes 4,376 3,579 (81.8) 797 (18.2)
No 11,772 10,253 (87.1) 1,519 (12.9)
Alcohol intake, n (%)  < .001
Yes 4,844 4,209 (86.9) 635 (13.1)
No 11,304 9,620 (85.1) 1,684 (14.9)
Diabetes, n (%) .531
Yes 1,130 961 (85.1) 169 (14.9)
No 15,018 12,915 (86.0) 2,103 (14.0)
Hypertension, n (%)
Yes 4,166 3,657 (87.8) 509 (12.2)  < .001
No 11,982 10,173 (84.9) 1,809 (15.1)
Employment status, n (%) .001
Employed 10,658 9,219 (86.5) 1,439 (13.5)
Unemployed 5,490 4,617 (84.1) 873 (15.9)
Work schedule .884
Daytime work 12,789 10,755 (84.1) 2,034 (15.9)
Evening work 1,583 1,321 (83.5) 262 (16.5)
Nighttime work 694 598 (86.2) 96 (13.8)
Shift work 1,082 903 (83.5) 179 (16.5)
Values are presented as mean ± SE for continuous variables and numbers (percentage) as indicated. a = P values are determined by weighted chi-square 
tests of categorical variables and by weighted analysis of variance of continuous variables. SE = standard error.
1101 Journal of Clinical Sleep Medicine, Vol. 13, No. 9, 2017
YJ Kwon, SY Jang, EC Park, et al. Sleep Duration and Sarcopenia
population had higher ORs of sarcopenia. Although the reason 
for this discrepancy is unclear, many external factors could af-
fect the relationship between sleep duration and sarcopenia in 
older people.
In subgroup analysis by BMI group, long sleep duration was 
significantly associated with sarcopenia in thin and normal 
weight groups after adjusting for the subjects’ age, sex, BMI, 
and household income, as well as current smoking, regular 
exercise, alcohol drinking, and hypertension statuses. How-
ever, after further adjustment of employment status, statistical 
significance was not present in thin patient groups. The small 
sample size could have caused sampling bias and affected the 
statistical significance.
The results of the current study are in line with a previous 
study suggesting that sleep duration was associated with sar-
copenia.28 Chien et al. demonstrated a U-shape association be-
tween sleep duration and sarcopenia. Specifically, the authors 
emphasized that those who had ≥ 8 hours of sleep tended to 
exhibit sarcopenia (OR [95% CI] = 1.89 [1.01–3.54]). Sex dif-
ferences were also shown in their study. In the sex-specific 
Table 2—Adjusted odds ratios of sarcopenia from logistic regression analysis.
General Population (n = 16,148) Healthy Population (n = 14,939)
Adjusted OR* 95% CI Adjusted OR* 95% CI
Sleep duration (hours)
≤ 5 0.934 0.672–1.298 0.966 0.686–1.359
6 1.084 0.816–1.440 1.116 0.831–1.500
7 1.000 1.000
8 1.238 0.600–1.597 1.162 0.897–1.505
≥ 9 1.589 1.100–2.295 1.570 1.071–2.301
Sex
Male 3.147 2.524–3.924 3.209 2.573–4.002
Female 1.000 1.000
Age (years) 1.006 0.997–1.014 1.006 0.998–1.014
Body mass index (kg/m2)
Thin 10.368 7.080–15.182 7.471 5.123–10.894
Normal 1.000 1.000
Overweight 0.056 0.031–0.100 0.062 0.034–0.111
Household income level
Q1 (Lowest) 1.013 0.702–1.464 1.034 0.706–1.516
Q2 1.065 0.782–1.450 1.032 0.750–1.419
Q3 1.117 0.828–1.507 1.094 0.812–1.474
Q4 (Highest) 1.000 1.000
Regular exercise
Yes 1.000 1.000
No 1.298 1.088–1.548 1.289 1.074–1.547
Current smoking
Yes 1.160 0.936–1.437 1.190 0.953–1.486
No 1.000 1.000
Alcohol intake
Yes 0.673 0.534–0.848 0.685 0.540–0.868
No 1.000 1.000
Hypertension
Yes 0.989 0.772–1.267 0.989 0.769–1.272
No 1.000 1.000
Employment status
Employed 0.655 0.567–0.757 0.732 0.543–0.985
Unemployed 1.000 1.000
Work schedule
Daytime work 1.000 1.000
Evening work 1.156 0.760–1.756 0.918 0.662–1.274
Nighttime work 0.806 0.474–1.370 0.849 0.489–1.472
Shift work 0.969 0.684–1.373 1.086 0.706–1.669
* = adjusted for age, sex, body mass index, household income, current smoking, regular exercise, alcohol drinking, hypertension, employment status, and 
work schedule. Healthy population = participants excluding patients in whom cancer, chronic kidney disease, liver disease, thyroid disease, rheumatism, 
stroke, angina, or myocardial infarction were diagnosed.
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analyses, only women showed the association. The current 
study had some different results; men with a long sleep dura-
tion (≥ 9 hours) were more likely to exhibit sarcopenia (OR 
[95% CI] = 1.574 [1.118–2.215]). In women, a U-shaped asso-
ciation was present, without any statistical significance. Al-
though the reason for this difference in the association between 
sleep duration, sarcopenia, and sex is unclear, there are sev-
eral discrepancies between the current study and Chien et al.’s 
study. In the current study, sleep duration was categorized into 
5 groups (≤ 5, 6, 7, 8 and ≥ 9 hours) whereas participants were 
Table 3—Odds ratios and 95% confidence intervals of sarcopenia by sleep duration from subgroup analysis.
Sleep Duration (hours)
≤ 5 6 7  8 ≥ 9
Total, n (%) 2,118 (12.9) 4,334 (26.4) 4,876 (29.7) 3,792 (23.1) 1,289 (8.0)
Sex
Male, OR (95% CI) 0.995 (0.757–1.308) 1.026 (0.820–1.285) 1.000 1.060 (0.852–1.319) 1.593 (1.153–2.200)
n (%) 802 (11.2) 2,097 (29.3) 2,176 (30.4) 1,596 (22.3) 487 (6.8)
Female, OR (95% CI) 1.187 (0.888–1.586) 0.962 (0.742–1.247) 1.000 1.226 (0.965–1.599) 1.242 (0.866–1.736)
n (%) 1,313 (14.6) 2,104 (23.4) 2,598 (28.9) 2,149 (23.9) 826 (9.1)
Age groups
20–39 years, OR (95% CI) 0.842 (0.569–1.246) 0.888 (0.681–1.158) 1.000 1.061 (0.820–1.374) 1.350 (0.954–1.191)
n (%) 487 (8.4) 1,495 (52.8) 1,808 (31.2) 1,495 (25.8) 509 (8.9)
40–64 years, OR (95% CI) * 1.320 (0.954–1.826) 1.214 (0.933–1.581) 1.000 1.330 (1.013–1.745) 1.868 (1.290–2.704)
n (%) 973 (13.1) 2,087 (28.8) 2,258 (30.4) 1,604 (21.6) 506 (6.1)
≥ 65 years, OR (95% CI) 0.890 (0.620–1.277) 0.803 (0.553–1.166) 1.000 0.817 (0.555–1.201) 0.886 (0.570–1.378)
n (%) 920 (28.8) 632 (19.8) 687 (21.5) 594 (18.6) 363 (11.4)
Body mass index
Thin, OR (95% CI) 1.502 (0.736–3.067) 1.213 (0.734–2.005) 1.000 1.289 (0.705–2.358) 1.621 (0.904–2.905)
n (%) 78 (9.7) 169 (20.9) 211 (26.1) 232 (28.8) 117 (14.4)
Normal, OR (95% CI) * 1.107 (0.825–1.253) 0.993 (0.826–1.194) 1.000 1.156 (0.965–1.384) 1.516 (1.181–1.945)
n (%) 1,253 (12.2) 2,639 (25.7) 3,081 (30.0) 2,464 (24.0) 833 (8.2)
Overweight, OR (95% CI) 0.785 (0.307–2.009) 0.668 (0.241–1.853) 1.000 0.932 (0.410–2.116) 0.592 (0.139–2.522)
n (%) 745 (14.7) 1,466 (28.9) 1,506 (29.7) 1,024 (20.2) 330 (6.5)
Health-related behaviors
Smoking
Yes, OR (95% CI) * 1.241 (0.853–1.806) 1.150 (0.844–1.567) 1.000 1.093 (0.797–1.501) 2.219 (1.387–3.550)
n (%) 512 (11.7) 1,238 (28.3) 1,252 (28.6) 1,020 (23.3) 354 (8.1)
No, OR (95% CI) 0.936 (0.743–1.179) 0.924 (0.757–1.129) 1.000 1.178 (0.962–1.442) 1.201 (0.912–1.580)
n (%) 1,566 (13.3) 3,025 (25.7) 3,543 (30.1) 2,708 (23.0) 930 (7.9)
Regular exercise
Yes, OR (95% CI) 1.103 (0.839–1.448) 1.069 (0.852–1.341) 1.000 1.046 (0.819–1.338) 1.422 (0.976–2.072)
n (%) 1,186 (13.7) 2,415 (27.9) 2,614 (30.2) 1,861 (21.5) 579 (6.7)
No, OR (95% CI) * 0.927 (0.696–1.236) 0.893 (0.705–1.131) 1.000 1.252 (1.002–1.565) 1.506 (1.139–1.991)
n (%) 892 (11.9) 1,851 (24.7) 2,180 (29.1) 1,866 (24.9) 704 (9.4)
Alcohol drinking
Yes, OR (95% CI) 1.073 (0.698–1.648) 0.921 (0.675–1.256) 1.000 1.243 (0.911–1.697) 1.578 (0.958–2.600)
n (%) 533 (11.0) 1,400 (28.9) 1,482 (30.6) 1,075 (22.2) 354 (7.3)
No, OR (95% CI) 1.008 (0.811–1.253) 1.014 (0.831–1.237) 1.000 1.108 (0.907–1.354) 1.417 (1.107–1.813)
n (%) 1,549 (13.7) 2,860 (25.3) 3,312 (29.3) 2,645 (23.4) 938 (8.2)
Employment status
Employed, OR (95% CI) 1.006 (0.782–1.294) 1.501 (0.851–1.297) 1.000 1.144 (0.922–1.420) 1.548 (1.141–2.100)
n (%) 1,268 (11.9) 3,112 (29.2) 3,304 (31.0) 2,345 (22.0) 629 (5.9)
Unemployed, OR (95% CI) 1.009 (0.728–1.399) 0.824 (0.610–1.115) 1.000 1.147 (0.871–1.511) 1.347 (0.941–1.928)
n (%) 813 (14.8) 1,158 (21.1) 1,488(27.1) 1,378 (25.1) 653 (11.9)
Odds ratios are adjusted for age, sex, body mass index, household income, current smoking, regular exercise, alcohol drinking, hypertension, employment 
status. Bonferroni correction for multiple testing was conducted. * = significant value of P < .05. CI = confidence interval, OR = odds ratio.
grouped into only 3 groups (< 6, 6–8, and ≥ 8 hours) in the 
study by Chien et al. Furthermore, the current study population 
included all Korean adults, not just older adults.
Although the underlying mechanisms of the relationship be-
tween sleep duration and sarcopenia remain unclear, there are 
some possible explanations. Some longitudinal studies have 
proposed a bidirectional relationship between sleep duration 
and body composition.29 We also found that sleep duration was 
related to sarcopenia by using 2 different analyses. Sleep du-
ration and sarcopenia shared common risk factors, and both 
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are important elements related to good health. Lifestyle fac-
tors including low physical activity, sedentary behavior, and 
smoking have been reported to accelerate the progression of 
sarcopenia.30 As for sleep duration itself, it can be affected by 
various lifestyle factors. Physical inactivity, sedentary life-
style, and low social economic status are all closely linked to 
sleep duration.31,32 One possible link between sleep duration 
and sarcopenia could be insulin resistance. A growing body 
of evidence supports that inappropriate amount of sleep du-
ration leads to unfavorable health effects. In two meta-anal-
yses, all-cause mortality was higher in those with long sleep 
duration.10,33 Also, Pyykkonen et al. reported that long sleep 
duration (≥ 9 hours) was closely related to increased insulin 
resistance after adjusting for confounding factors.14 Also, Bro-
cato et al. documented that long sleepers were more likely to 
have metabolic syndrome components.34 Despite these obser-
vations, the exact mechanism and causality remain unclear, 
and some authors have suggested that insulin resistance and 
sarcopenia share a common cause.4 Rasmussen et al. proposed 
that resistance to insulin contributed to a decline in the syn-
thesis of skeletal mass protein and resulted in sarcopenia in 
older people.35 In addition, circadian rhythm disruption and 
hormonal changes with long sleep duration might be a possible 
underlying mechanism to explain the relationship between 
sleep duration and sarcopenia.36 Also, another link between 
sleep duration and sarcopenia could be chronic inflammation.37 
Patel et al. suggested that increased sleep duration was related 
to a proinflammatory marker such as C-reactive protein and in-
terleukin-6.37 These inflammatory mediators play an important 
role in sarcopenia by provoking muscle proteolysis.38 Finally, 
Stranges et al. proposed that low socioeconomic status and un-
disclosed general medical conditions are both associated with 
long sleep duration,39 and Coppin et al. found low socioeco-
nomic status is closely related to physiological impairment.40 
Together, these recent studies have shown habitual long sleep 
duration to be associated with unhealthy outcomes. However, 
there are no studies to date that demonstrate an exact mecha-
nism of the relationship between long sleep duration and ad-
verse health effects.
Although our study did not find significant association 
between short sleep duration and sarcopenia, sleep depriva-
tion remains a major problem against healthy lifestyle. Many 
studies have demonstrated that short sleep duration leads to 
coronary heart disease and diabetes, which are closely linked 
to chronic inflammation and insulin resistance.41 Other stud-
ies have reported that both short and long sleep durations are 
related to sarcopenia in older females.28 Further prospective 
studies are required to clarify the relationship between sleep 
duration and sarcopenia.
This study had some limitations. First, participant data 
such as sleep duration, smoking habits, alcohol intake, exer-
cise habits, employment status, and work schedule were all 
obtained via self-reported questionnaires, rather than by ob-
jective measures. Second, despite the significant relationship 
between long sleep duration and sarcopenia found in the cur-
rent study, we cannot conclude whether long sleep duration is 
a risk factor for sarcopenia or just an epiphenomenon. Because 
of this study’s cross-sectional design, our results should be 
cautiously interpreted, and prospective longitudinal studies 
are warranted. Third, we did not consider the sleep quality and 
sleep-wake phase of the participants, both of which were not 
part of the 2008–2011 KNHANES. Thus, we were not able to 
assess possible association between circadian disruption and 
sarcopenia. Fourth, the question regarding the sleep duration 
had not been distinguished for the weekend and weekdays. 
Therefore, the actual sleep duration could have been longer. 
Fifth, the proportions of sarcopenia varied largely according to 
BMI. Previous studies have reported that underweight and low 
BMI were significant risk factors for sarcopenia.27 Therefore, 
low BMI could attenuate the association between sleep dura-
tion and sarcopenia. Additionally, although dual-energy x-ray 
absorptiometry is a useful tool for estimating muscle mass, in-
homogeneous adipose tissue may have caused some accuracy 
errors in soft tissue; therefore, our results should be interpreted 
with caution.42 Further studies using either computed tomogra-
phy or magnetic resonance imaging are needed, and the effect 
of lean body mass on sarcopenia also needs more investigation. 
Finally, there may be other residual factors that we did not ad-
equately take into account.
Nevertheless, our study has several strengths. First, this is 
the first observational study to assess the relationship between 
sleep duration and sarcopenia in a large sample population. 
Second, we used stratified, multistage probability sampling 
data and applied sample weights for the analyses. Therefore, 
our findings are more generalizable to the Korean adult popu-
lation. In conclusion, we found that long sleep duration was in-
dependently associated with sarcopenia in Korean adults after 
adjusting for age, sex, BMI, household income, hypertension, 
exercise habits, smoking, alcohol consumption, employment 
status, and work schedule using a nationally representative da-
taset. However, future studies are needed to demonstrate this 
causal relationship and elucidate the biological mechanisms 
that underlie this association.
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